Division of Pharmacy, Eastern Chiba Medical Center.
Department of General Medical Sciences, Graduate School of Medicine, Chiba University.
Yakugaku Zasshi. 2024;144(10):963-968. doi: 10.1248/yakushi.24-00075.
Blood purification therapy with cytokine-adsorbing hemofilters has been used to treat sepsis-associated hypercytokinemia. Polymethylmethacrylate (PMMA) hemofilters are frequently used for this purpose; however, adsorption and removal of teicoplanin, a therapeutic agent, have been reported. Similar concerns have been shared regarding daptomycin because its structure resembles that of teicoplanin; nevertheless, there have been no reported effects associated with daptomycin in this context. We studied the adsorption of daptomycin onto a PMMA hemofilter in vitro and investigated its adsorption onto hollow fiber membranes by adding cut PMMA membranes to a daptomycin solution. Additionally, the daptomycin solution was circulated in a dialysis circuit connected to a PMMA hemofilter, and changes in daptomycin content were examined. The daptomycin content decreased immediately after adding the hollow fiber membranes, similar to that observed for teicoplanin. The daptomycin content was lower than that of the standard reagent in the dialysis circuit model, reaching values below the measurement limit after 20 min. These results suggested that daptomycin was adsorbed and removed by the PMMA hemofilter. Encountering this effect during clinical use is plausible; therefore, daptomycin administration via a PMMA hemofilter should be avoided during blood purification therapy.
血液净化疗法联合细胞因子吸附型血液滤过器已被用于治疗脓毒症相关的细胞因子血症。聚甲基丙烯酸甲酯(PMMA)血液滤过器常用于此目的;然而,已有报道称其可吸附和清除替考拉宁这种治疗药物。由于达托霉素的结构类似于替考拉宁,因此人们对其也存在类似的担忧;然而,在这种情况下,尚未有报道称达托霉素会产生相关影响。我们在体外研究了达托霉素在 PMMA 血液滤过器上的吸附情况,并通过向达托霉素溶液中添加切割的 PMMA 膜来研究其在中空纤维膜上的吸附情况。此外,将达托霉素溶液在连接到 PMMA 血液滤过器的透析回路中循环,并检查达托霉素含量的变化。达托霉素含量在添加中空纤维膜后立即下降,与替考拉宁的观察结果相似。在透析回路模型中,达托霉素的含量低于标准试剂,20 分钟后降至检测限以下。这些结果表明达托霉素被 PMMA 血液滤过器吸附和清除。在临床应用中遇到这种情况是合理的;因此,在血液净化治疗期间,应避免通过 PMMA 血液滤过器给予达托霉素。